Literature DB >> 7598936

Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

S A Green1, J Turki, P Bejarano, I P Hall, S B Liggett.   

Abstract

The phenotypic relevance of allelic variation in the structure of the beta 2-adrenergic receptor (beta 2AR) expressed in lung cells is unknown. In particular, altered responsiveness of the beta 2AR expressed on airway smooth muscle, which are responsible for bronchodilation in the treatment of asthma, may be an important factor in the ultimate physiologic response to agonist. To approach this, we established primary cultures of human airway smooth muscle cells obtained at autopsy and developed a method to determine the beta 2AR genotype at the polymorphic loci of codons 16 and 27, using allele-specific polymerase chain reactions. Radioligand binding studies revealed that these cells expressed approximately 70 fmol/mg of receptor which was exclusively of the beta 2AR subtype. All cell lines obtained (n = 10) exhibited normal agonist binding and receptor-mediated activation of the adenylyl cyclase second messenger pathway. However, distinct differences were found in the response to long-term agonist exposure between the different beta 2AR genotypes. Cells expressing Arg at codon 16 (Arg16) traditionally referred to as wild-type, underwent 77.8 +/- 8.1% downregulations of beta 2AR following prolonged (24-h) exposure to the beta 2AR agonist isoproterenol (10 microM). In contrast, cells expressing Gly16 beta 2AR underwent enhanced agonist-promoted downregulation (95.6 +/- 1.7%, P < 0.05 versus Arg16), whereas cells expressing Glu27 beta 2AR were relatively resistant to such downregulation (29.5 +/- 12.7%, P < 0.01 versus Arg16). For cells expressing Glu27 beta 2AR, this difference resulted in a significant attenuation of agonist-promoted functional desensitization (33 +/- 7 versus 90 +/- 5% desensitization for Arg16, P < 0.001) following preincubation with 1 microM isoproterenol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598936     DOI: 10.1165/ajrcmb.13.1.7598936

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  119 in total

1.  Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene.

Authors:  M G Scott; C Swan; A P Wheatley; I P Hall
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 2.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

Review 3.  Pharmacogenetics of asthma.

Authors:  A Fenech; Ian P Hall
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

Review 4.  Genetic polymorphisms of adrenergic receptors.

Authors:  E M Garland; I Biaggioni
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

Review 5.  Cardiac receptor physiology and its application to clinical imaging: present and future.

Authors:  H Tseng; J M Link; J R Stratton; J H Caldwell
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

6.  Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.

Authors:  D R Taylor; J M Drazen; G P Herbison; C N Yandava; R J Hancox; G I Town
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

Review 7.  Pharmacogenetics and the future of medical practice.

Authors:  Klaus Lindpaintner
Journal:  J Mol Med (Berl)       Date:  2003-03-25       Impact factor: 4.599

Review 8.  Pharmacogenetics of asthma.

Authors:  John J Lima; Kathryn V Blake; Kelan G Tantisira; Scott T Weiss
Journal:  Curr Opin Pulm Med       Date:  2009-01       Impact factor: 3.155

9.  Limited impact of multiple 5' single-nucleotide polymorphisms on the transcriptional control of the human beta 2-adrenoceptor gene.

Authors:  Robert Westland; Anneke van Veen; Henk M Jansen; Rene E Jonkers; Eddy A Wierenga
Journal:  Immunogenetics       Date:  2004-11-17       Impact factor: 2.846

Review 10.  Pharmacogenetics of the beta 2-adrenergic receptor gene.

Authors:  Victor E Ortega; Gregory A Hawkins; Stephen P Peters; Eugene R Bleecker
Journal:  Immunol Allergy Clin North Am       Date:  2007-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.